Genetically engineered mouse models with loss of Pten develop goiter and in some cases, thyroid cancers with variable frequencies ranging from 0 to 65% depending on the genetic background25–27 in an Akt128 or Akt2-dependent manner29. This evidence concerns the gene AKT2 and thyroid gland carcinoma.